Interleukin 2 Receptor, Alpha, Deficiency of
|
0.710 |
GermlineCausalMutation
|
disease |
ORPHANET |
Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor.
|
9096364 |
1997 |
Interleukin 2 Receptor, Alpha, Deficiency of
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Follicular bronchiolitis as phenotype associated with CD25 deficiency.
|
24116927 |
2014 |
Interleukin 2 Receptor, Alpha, Deficiency of
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity.
|
23416241 |
2013 |
Interleukin 2 Receptor, Alpha, Deficiency of
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Interleukin 2 Receptor, Alpha, Deficiency of
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
These data show that CD25 deficiency results in an IPEX-like syndrome and suggests that although Foxp3 is not required for normal IL-10 expression by human CD4 lymphocytes, CD25 expression is important.
|
17196245 |
2007 |
Interleukin 2 Receptor, Alpha, Deficiency of
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
These data show that CD25 deficiency results in an IPEX-like syndrome and suggests that although Foxp3 is not required for normal IL-10 expression by human CD4 lymphocytes, CD25 expression is important.
|
17196245 |
2007 |
Interleukin 2 Receptor, Alpha, Deficiency of
|
0.710 |
Biomarker
|
disease |
BEFREE |
PBC is virtually absent in children with the exception of one reported child with interleukin 2 receptor α (CD25) deficiency which is associated with an IPEX-like regulatory T cell dysfunction.
|
20650610 |
2010 |
Interleukin 2 Receptor, Alpha, Deficiency of
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Follicular bronchiolitis as phenotype associated with CD25 deficiency.
|
24116927 |
2014 |
Interleukin 2 Receptor, Alpha, Deficiency of
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Interleukin 2 Receptor, Alpha, Deficiency of
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
Rheumatoid Arthritis
|
0.500 |
Biomarker
|
disease |
BEFREE |
This underlines the relevance of IL2RA for RA.
|
26350950 |
2015 |
Rheumatoid Arthritis
|
0.500 |
Biomarker
|
disease |
CTD_human |
We observed an increased expression of full-length FoxP3 mRNA in RA patients when compared to healthy controls, as well as an increase in CD25 mRNA expression, but no corresponding increase in CTLA-4 mRNA expression.
|
20476861 |
2010 |
Rheumatoid Arthritis
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells.
|
20007590 |
2009 |
Rheumatoid Arthritis
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.
|
20453842 |
2010 |
Rheumatoid Arthritis
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
Genetics of rheumatoid arthritis contributes to biology and drug discovery.
|
24390342 |
2014 |
Rheumatoid Arthritis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Phenotypic, Functional, and Gene Expression Profiling of Peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) Treg Cells in Patients With Chronic Rheumatoid Arthritis.
|
26314565 |
2016 |
Rheumatoid Arthritis
|
0.500 |
Biomarker
|
disease |
CTD_human |
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.
|
20453842 |
2010 |
Rheumatoid Arthritis
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Genetics of rheumatoid arthritis contributes to biology and drug discovery.
|
24390342 |
2014 |
Rheumatoid Arthritis
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Within the CD4 T lymphocytes subset we found that the CD45RO- (naive) cells selectively in RA displayed higher levels of CD25 protein and of interferon-gamma mRNA expression when compared with the respective subset of all other investigated groups.
|
1347492 |
1992 |
Rheumatoid Arthritis
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.
|
23143596 |
2012 |
Rheumatoid Arthritis
|
0.500 |
Biomarker
|
disease |
CTD_human |
High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.
|
23143596 |
2012 |
Rheumatoid Arthritis
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome-wide association study.
|
24449572 |
2014 |
Rheumatoid Arthritis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We observed an accumulation of rare nonsynonymous variants exclusive to RA cases in IL2RA and IL2RB (burden test: p = 0.007 and p = 0.018, respectively).
|
23261300 |
2013 |
Rheumatoid Arthritis
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
DNA microarray analysis of peripheral blood lymphocytes showed significant increase of interleukin (IL)-2 receptor α-chain (CD25) gene expression, a regulatory T cell (Treg) surface marker in severe RA patients.
|
21670968 |
2012 |
Rheumatoid Arthritis
|
0.500 |
Biomarker
|
disease |
BEFREE |
CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg) are involved in several autoimmune diseases, including rheumatoid arthritis.
|
21346237 |
2011 |